IRIS
LUS, Giacomo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.423
NA - Nord America 4.003
AS - Asia 3.244
SA - Sud America 624
AF - Africa 46
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 17.349
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 6.182
US - Stati Uniti d'America 3.929
SG - Singapore 1.286
IE - Irlanda 951
CN - Cina 772
IT - Italia 557
BR - Brasile 550
HK - Hong Kong 536
UA - Ucraina 429
GB - Regno Unito 394
DE - Germania 334
VN - Vietnam 175
KR - Corea 154
FR - Francia 152
FI - Finlandia 126
SE - Svezia 88
IN - India 82
TR - Turchia 71
GR - Grecia 68
JP - Giappone 45
AR - Argentina 39
MX - Messico 31
BE - Belgio 29
CA - Canada 26
HU - Ungheria 21
AT - Austria 20
IR - Iran 20
BD - Bangladesh 17
IQ - Iraq 17
ID - Indonesia 14
PL - Polonia 14
NL - Olanda 13
PK - Pakistan 12
ZA - Sudafrica 12
EC - Ecuador 10
CZ - Repubblica Ceca 9
ES - Italia 9
MA - Marocco 8
TN - Tunisia 8
CO - Colombia 7
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
EG - Egitto 5
IL - Israele 5
UZ - Uzbekistan 5
JO - Giordania 4
KE - Kenya 4
KZ - Kazakistan 4
LT - Lituania 4
PY - Paraguay 4
RS - Serbia 4
UY - Uruguay 4
VE - Venezuela 4
AU - Australia 3
BG - Bulgaria 3
BO - Bolivia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
EU - Europa 3
HN - Honduras 3
LB - Libano 3
SA - Arabia Saudita 3
BB - Barbados 2
BY - Bielorussia 2
KG - Kirghizistan 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
AO - Angola 1
AZ - Azerbaigian 1
BH - Bahrain 1
CG - Congo 1
CL - Cile 1
DK - Danimarca 1
DZ - Algeria 1
GA - Gabon 1
IS - Islanda 1
KW - Kuwait 1
MD - Moldavia 1
MK - Macedonia 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 17.349
Salva come PNG Salva come JPEG
Città #
Moscow 2.187
Dublin 951
Santa Clara 626
Jacksonville 594
Chandler 578
Hong Kong 532
Singapore 498
Seoul 152
Ann Arbor 146
Princeton 143
Beijing 141
Hefei 133
Roxbury 112
Ashburn 107
Medford 99
Bremen 96
Caserta 88
Dallas 88
Naples 85
The Dalles 70
Boardman 68
Munich 64
New York 60
Wilmington 59
Ho Chi Minh City 58
Woodbridge 57
Bengaluru 50
Cambridge 50
São Paulo 47
San Mateo 39
Los Angeles 37
Hanoi 36
Brussels 27
Milan 27
Norwalk 24
Nuremberg 23
Des Moines 22
Aversa 19
Rio de Janeiro 19
Jinan 18
Helsinki 17
Houston 17
Dong Ket 14
Nanjing 14
Rome 14
Tianjin 14
Turku 14
Belo Horizonte 13
Guarulhos 11
Redwood City 11
Curitiba 10
Falkenstein 10
Luzzano 10
Mountain View 10
Düsseldorf 9
Porto Alegre 9
San Francisco 9
Seattle 9
Vienna 9
Auburn Hills 8
Brasília 8
Joinville 8
Siano 8
Warsaw 8
Baghdad 7
Boston 7
Chicago 7
Columbus 7
Cuiabá 7
Guangzhou 7
Haiphong 7
Mexico City 7
Napoli 7
Stockholm 7
Taizhou 7
Toronto 7
Zhengzhou 7
Amsterdam 6
Bauru 6
Biên Hòa 6
Casablanca 6
Changsha 6
Chennai 6
Hangzhou 6
Hyderabad 6
Karachi 6
Ninh Bình 6
Phoenix 6
Shenyang 6
Thái Bình 6
West Jordan 6
Harbin 5
Lanzhou 5
London 5
Nanchang 5
Quarto 5
Reggio Nell'emilia 5
Ribeirão Preto 5
Salerno 5
Santa Maria 5
Totale 8.714
Salva come PNG Salva come JPEG
Nome #
INSOLITO PNEUMOCEFALO IPERTESO DA OSTEOMA DEL SENO FRONTALE 218
Abnormal accumulation of tTGase products in muscle and erythrocytes of chorea-acanthocytosis patients 188
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone. 173
Modifications moleculaires au cours de la regeneration et reinnervation musculaires in vitro 167
A cluster of progranulin C157KfsX97 mutations in Southern Italy: clinical characterization and genetic correlations 163
12-months prospective Pentraxin-3 and metabolomic evaluation in multiple sclerosis patients treated with glatiramer acetate 157
Chronic HCV infection and neurological and psychiatric disorders: an overview. 152
Epstein Barr virus infection reactivation as a possible trigger of primary biliary cirrhosis-like syndrome in a patient with multiple sclerosis in the course of fingolimod treatment. 147
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 147
Synergistic Interplay between Curcumin and Polyphenol-Rich Foods in the Mediterranean Diet: Therapeutic Prospects for Neurofibromatosis 1 Patients 146
Biochemical and morphological evidences supporting the hypothesis of a role of TGase in the pathogenesis of chorea acanthocytosis (C-A) 146
Adiponectin profile at baseline is correlated to progression and severity of multiple sclerosis 145
Biochemical and morphological evidences supporting the hypothesis of a role of Tgase in the pathogeneisi of Chorea-Acanthocytosis 141
Alemtuzumab significantly improves posterior fossa syndrome presented as a relapse of multiple sclerosis 137
Adiponectin in Cerebrospinal Fluid from Patients Affected by Multiple Sclerosis Is Correlated with the Progression and Severity of Disease 137
Preliminary results of the FASM study, an on-going italian active pharmacovigilance project 136
A new tRNAHis mutation in the mtDNA results in mitochondrial encephalomyopathy by hampering ATP production 134
Biochemical and morphological evidences supporting the hypothesis of a role of TGase in the pathogenesis of chorea acanthocytosis (C-A) 133
Malattie dei nervi periferici 133
Associations between cognitive impairment at onset and disability accrual in young people with multiple sclerosis 133
[Ambulatory monitoring of arterial pressure in the diagnosis and therapeutic evaluation of dysautonomic diseases: observations in a case of Shy-Drager syndrome] 131
Analisi in istofluorescenza di densità e distribuzione dei recettori per ConA e WGA in corso di rigenerazione e re-innervazione nel muscolo scheletrico di ratto ischemizzato e denervato, reversibilmente o irreversibilmente 130
Rasagiline improves sleep disorders in Parkinson's disease 129
Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis 129
Apparently isolated CNS involvement in Erdheim-Chester disease: Case report 128
[Unusual histo-cytopathologic findings in a familial case of stiff spine syndrome] 128
Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence 127
Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. 127
Myoplasticity and myoregeneration; from molecular aspects to clinical perspectives 126
An unusual phenotype of familial motor and sensory neuropathy with morphological features of HMSN1 126
Angiogenesis and Multiple Sclerosis Pathogenesis: A Glance at New Pharmaceutical Approaches 125
Lymphocytosis as a response biomarker of natalizumab therapeutic efficacy in multiple sclerosis 125
BMI influences CD20 kinetics in multiple sclerosis patients treated with ocrelizumab 125
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration 125
39. Density and distribution of ConA and WGA receptors determined by histofluorescence analysis during degeneration, regeneration and reinnervation of the rat skeletal muscle following ischemia and reversible or irreversible denervation. , : , 122
Assessment of Multiple Sclerosis Disability Progression Using a Wearable Biosensor: A Pilot Study 122
Cd19 cell count at baseline predicts b cell repopulation at 6 and 12 months in multiple sclerosis patients treated with ocrelizumab 120
Cecità e diplopia come espressione isolata di metastasi mesencefalica:considerazioni neuroradiologiche neurologiche e neurochirurgiche.A proposito di 2 casi 119
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 119
Myopathic changes in neurofibromatosis type 1 118
A cluster of progranulin C157KfsX97 mutation in southern Italy- clinical characterization and genetic correlations 118
CECITÀ E DIPLOPIA COME ESPRESSIONE ISOLATA DI METASTASI MESENCEFALICHE: CONSIDERAZIONI NEURORADIOLOGICHE, NEUROLOGICHE E NEUROCHIRURGICHE A PROPOSITO DI DUE CASI” 117
Multiple sclerosis and genetic polymorphisms in fibrinogen-mediated hemostatic pathways: a case–control study 117
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 116
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases. 116
NEURO-DEGENERAZIONE CON ACCUMULO CEREBRALE DI FERRO TIPO 1 (NIBA TIPO1), UNA NUOVA FAMIGLIA CON MALATTIA DI HALLERVORDEN SPATZ A DECORSO CLINICO PROTRATTO 116
Correction to: Adiponectin in Cerebrospinal Fluid from Patients Affected by Multiple Sclerosis Is Correlated with the Progression and Severity of Disease 116
Retrospective epidemiology of Duchenne muscular dystrophy in Molise 115
Disability assessment using Google Maps 115
A real-world study of alemtuzumab in a cohort of Italian patients 115
CTG repeat number in the nonaffected allele of myotonic dystrophy patients is not critical for disease expression 114
Unusual manifestation of vertebral osteoid osteoma: case report 113
Azathioprine and interferon beta(1a) in relapsing-remitting multiple sclerosis patients: increasing efficacy of combined treatment. 113
Clinical predictors of Dimethyl Fumarate response in multiple sclerosis: a real life multicentre study 113
A snapshot on patient-reported outcome measures of people with multiple sclerosis on first-line therapies in a real world setting 113
LA NEUROMIELITE OTTICA È UN’ ASSOCIAZIONE SINDROMICA COMUNE A PATOLOGIE ETEROGENEE 111
Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab 110
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients 109
Autoantibodies in multiple sclerosis patients before and during IFN-β1b treatment: Are they correlated with the occurrence of autoimmune diseases? 109
C’È UN GUADAGNO DIAGNOSTICO IN RM DELLE SACNSIONI TARDIVE OPO DOSE TRIPLA DI GADOLINIO NELL’IDENTIFICAZIONE DI PLACCHE ATTIVE DI SCLEROSI MULTIPLA? * Risultati preliminari 109
Clinical and Genetic Heterogeneity in a Large Family with Pseudoxanthoma Elasticum: MTHFR and SERPINE1 Variants as Possible Disease Modifiers in Developing Ischemic Stroke 109
Long-term effects of asymmetrical posture in boxing assessed by baropodometry 109
Reperti isto e citopatologici del tutto peculiari riscontrati in un caso familiare di sindrome della spina rigida 108
Fingolimod efficacy in multiple sclerosis associated with Sjogren syndrome 107
Animal model to study factors influencing regeneration and direct innervation or neurotization of skeletal muscle 107
Health related quality of life in the domain of physical activity predicts confirmed disability progression in people with relapsing remitting multiple sclerosis 106
Signs and symptoms of COVID-19 in patients with multiple sclerosis 106
Isolated transient blindness and isolated oculomotor nerve palsy secondary to single mesencephalic metastases: report of 2 cases 106
Natalizumab vs interferon beta 1a in relapsing-remitting multiple sclerosis: a head-to-head retrospective study. 106
Are giant axons a pathological marker of charcot-marie-tooth neuropathy type 2E? 106
Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice. 105
La capacità rigenerativa del muscolo scheletrico danneggiato: studio sperimentale 105
Histopathological heterogeneity and cytopathological similarity of findings in different muscles of two brothers affected by rigid spine syndrome 104
Therapeutic Plasmapheresis: a revision of literature 103
Revelation of a new mitochondrial DNA mutation (G12147A) in a MELAS/MERFF phenotype. 103
Treatment withdrawal in relapsing-remitting multiple sclerosis: a retrospective cohort study 103
Migraine as possible red flag of PFO presence in suspected demyelinating disease 103
Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study 101
CORRELATI CLINICO-STRUMENTALI IN UN CASO DI CREUTZFELD- JACOB A LUNGA SOPRAVVIVENZA. 101
Prognostic indicators in pediatric clinically isolated syndrome 101
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity 101
Progressive rubella panencephalitis. Follow-up EEG study of a case 100
Dalla malattia di Schilder all’adrenoleucodistrofia; una breve storia di un secolo di ricerca neuropatologica clinica esemplare 99
Fluctuations of MS births and UV-light exposure. 98
The OPTimization of interferon for MS study: 375 microg interferon beta-1b in suboptimal responders 98
The Rise of the GRN C157KfsX97 Mutation in Southern Italy: Going Back to the Fall of the Western Roman Empire 98
Adiponectin Alleviates Cell Injury due to Cerebrospinal Fluid from Multiple Sclerosis Patients by Inhibiting Oxidative Stress and Proinflammatory Response 98
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis 97
Role of Ocrelizumab in modulating gene and microRNA expression in multiple sclerosis 97
Natalizumab in pediatric multiple sclerosis: results of a cohort of 55 cases 97
Atorvastatin Combined To Interferon to Verify the Efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy 97
Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic 96
Dalla malattia di Schilder alla adrenoleucodistrofia: una breve storia di un secolo di ricerca neuropatologica clinica esemplare 96
The EDSS integration with the Brief International Cognitive Assessment for Multiple Sclerosis and orientation tests 95
Quantitative Evaluation of Upright Posture by x-Ray and 3D Stereophotogrammetry with a New Marker Set Protocol in Late Onset Pompe Disease 94
Post-marketing of disease modifying drugs in multiple sclerosis: An exploratory analysis of gender effect in interferon beta treatment. 93
AZATIOPRINA E INTERFERONE - 1° NEI PAZIENTI CON SCLEROSI MULTIPLA RECIDIVANTE REMITTENTE: INCREMENTO DELL’EFFICACIA DEL TRATTAMENTO COMBINATO. 91
Intracranial extension of orbital inflammatory pseudotumor: A case report and literature review 91
Normalization of short-chain acylcoenzyme A dehydrogenase after riboflavin treatment in a girl with multiple acylcoenzyme A dehydrogenase-deficient myopathy 90
Diffuse glioblastoma resembling acute hemorrhagic leukoencephalitis 90
Totale 11.824
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.694
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.694
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021524 0 0 0 0 0 17 130 102 22 122 88 43
2021/20221.067 52 132 10 27 292 9 27 34 37 68 97 282
2022/20232.026 171 36 32 185 240 179 2 134 923 20 60 44
2023/2024731 70 21 48 56 252 60 10 25 6 3 57 123
2024/20252.675 6 45 40 74 399 406 298 201 393 420 235 158
2025/20268.600 323 424 556 524 895 5.878 0 0 0 0 0 0
Totale 17.748